ScreenerHero

PRPO Precipio, Inc.

NAS · US · Healthcare · Diagnostics & Research · precipiodx.com
23.52USD+0.30%Mkt Cap: 42.11M $P/E: —

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap42.11M USD
Enterprise Value42.49M USD
Revenue (TTM)27.20M USD
Gross Profit10.71M USD
Net Income (TTM)-363.00K USD
Revenue/Share15.60 USD
Last Price23.52 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees61
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)60.13
PEG—
EV/EBITDA-329.40
EV/Revenue1.56
P/S1.54
P/B2.84
EPS (TTM)-0.64
EPS (Forward)0.39
52W Range
16.4041% of range33.63
52W High33.63 USD
52W Low16.40 USD
Profitability
Gross Margin44.52%
Oper. Margin-8.53%
EBITDA Margin-0.47%
Profit Margin-1.51%
ROE-2.49%
ROA-1.70%
Growth
Revenue Growth24.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF685.00K USD
CapEx (TTM)326.00K USD
FCF Margin4.95%
FCF Yield3.20%
Net Debt513.00K USD
Net Debt/EBITDA-3.98
Balance Sheet
Debt/Equity0.25
Current Ratio1.77
Quick Ratio1.45
Book Value/Sh8.25 USD
Cash/Share1.72 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 29, 2019
Splits
Last Split1:20
Split DateSep 22, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.79M
Float1.41M
Insiders12.63%
Institutions17.71%
Short Interest
Short Ratio0.4d
Short % Float4.53%
Short % Out.4.12%
Shares Short73.78K
Short (prev mo.)51.53K
Technical
SMA 5025.42 (-7.5%)
SMA 20025.22 (-6.7%)
Beta1.30
S&P 52W Chg16.45%
Avg Vol (30d)108.64K
Avg Vol (10d)52.05K
Technical Indicators
RSI (14)43.2
MACD-0.6589
MACD Signal-0.4111
MACD Hist.-0.2478
BB Upper28.51 USD
BB Middle25.09 USD
BB Lower21.66 USD
BB Width27.29%
ATR (14)1.451 USD
Vol Ratio (20d)0.62x